Only one big loser this week, and that was TND:Tandem Group dropping 6% to go 33% down. There's no obvious reason for the fall, but in the past this one has fallen on days with no trades at all.
BLU:Blue Star Capital climbed 6% but has a long way to go, as it's still 64% down. This needs Satoshipay to launch something with a major publisher before anything more dramatic happens to recover my losses.
SBTX:SkinBioTherapeutics keeps sneaking up, climbing another 7% this week and going £95 (9%) into profit. The more this climbs, the more it's worth to OPTI:Optibiotix and hopefully the more my free shares will be worth when they are dished out.
OPTI:Optibiotix should win Share of the Week, with the 6p climb increasing value by 9% and increasing my potential profits to £4,300 making this Star Share. This knocks CAML:Central Asia Metals off its perch with £2,331 potential profit, albeit a much higher percentage of the smaller purchase cost.
There is one share that performed better. IQE:IQE has been under loads of pressure recently, making me glad I sold out for a huge profit just before OPTI:Optibiotix started waking up. However, this week there was an 11% climb, reducing my paper loss in the SIPP to 5% and winning Share of the Week.
I was never in any doubt! Well, maybe a little bit of doubt, but with a kind wind maybe next week the lines could cross?
| Weekly Change | |||
| Cash | £7.11 | +£0 | |
| Portfolio cost | £51,874.49 | +£0 | |
| Portfolio sell value (bid price - commission) | £48,234.84 | (-7%) | +£2,413.37 |
| Potential profits | £2,797.49 | +£2,440.79 | |
| Yr 3 Dividends | £44.15 | +£0 | |
| Yr 3 Profit from sales | £8,033.77 | +£0 | |
| Yr 3 Average monthly cash profit | £871.45 | (20.2%) | -£22.35 |
| Total Dividends | £1,223.20 | +£0 | |
| Total Profit from sales | £14,746.27 | +£0 | |
| Average monthly cash profit | £476.38 | (11%) | -£3.33 |
| (Sold stocks profit + Dividends - Fees / Months) |
A fantastic performance from OPTI:Optibiotix countering some smaller losses throughout the portfolio, with pretty much all the increase going directly to paper profit.
Still quite a big gap to make up.
The SIPP looks like this after week 128
| Weekly Change | |||
| Cash | £30.03 | +£20.69 | |
| Portfolio cost | £27,291.98 | +£275.74 | |
| Portfolio sell value (bid price - commission) | £30,357.64 | (11.2%) | +£1,469.15 |
| Potential profits | £4,442.76 | +£1,204.13 | |
| Yr 3 Dividends | £0 | +£0 | |
| Yr 3 Profit from sales | £1,299.03 | +£275.19 | |
| Yr 3 Average monthly cash profit | £223.34 | (9.8%) | +£42.14 |
| Total Dividends | £916.10 | +£0 | |
| Total Profit from sales | £10,224.22 | +£275.19 | |
| Average monthly cash profit | £370.04 | (16.3%) | +£6.47 |
| (Sold stocks profit + Dividends - Fees / Months) |
This is a bit more complicated than usual, as I was a bit naughty. I keep an eye on my old shares, and I'd been watching MMX:Minds+Machines particularly closely lately. They were one of my early purchases, as I was interested in their potential as a low cost high income company, assuming the new types of domain names they sell take off. I had a few doubts, so sold out. One holding made £20 (3.2%) profit and the other made £40 (3.9%) loss so I'm £20 down in my dealings with them. At the time their share price was around 9p.
I watched the price rise as they got more renewals and looked like making a profit. It peaked at around 13.5p last August and I figured I had lost my chance. Recently that had dropped to around 10.5p, but then crashed to 7.5p last week after news they were buying out an American company that owns a set of adult domain names.
So, the day they announce maiden profit is the same day they announce all their cash has been spent, and further share dilution. This clearly annoyed many holders who expected the opposite - that the company would be bought out and a big return paid out to shareholders. Instead they were locked into a bigger company having to wait up to 2 years to see any return. Some holders are also upset at the purchase of adult web domains. However, in an area where regulation is important, anyone visiting one of these sites will know they are on a regulated site, and not a random .com site, so if this causes many unregulated .com sites to close down as people stop visiting, then it's surely a good thing?
So a cash generative company buys another cash generative company and the share price gets thumped. That the type of crazy I like, so I sold half my SIPP holding in LGEN:Legal & General. This was 372 shares at 280.63p after paying 197.7p so a profit of £275.19 (38.8%).
I purchased 13,184 shares in MMX:Minds+Machines at 7.58p costing £1,011.30. They snuck into profit on day one but slipped on day 2 to £34 (3%) loss. That's mainly commission as the offer price is still 7.7p so higher than I paid. My plan is to let these recover when people realise it's a good deal, then sell them and put the money back into LGEN:Legal & General as this is a nice safe SIPP share. As long as I can buy back more than the 372 shares I sold, then I'll be happy.
It does mean my SIPP is now invested in both porno websites and viagra pills though!
The effect of the trades was to increase my cash to the minimum amount allowed, up the portfolio cost by £275 as the profits were re-invested, and increase long-term average monthly performance by £6 a month to £370 (16.3%). Not a huge difference but every little helps. Meanwhile OPTI:Optibiotix took the paper profits and portfolio value up by around £1,200 which was nice.
Yippee!! That's more like it! Highest ever portfolio value.
Here's the cursed trading account at week 94
| Weekly Change | |||
| Cash | £0.03 | +£0 | |
| Portfolio cost | £345.65 | +£0 | |
| Portfolio sell value (bid price - commission) | £180.22 | (-47.9%) | +£11.09 |
| Potential profits | £0 | +£0 | |
| Year 2 Dividends | £0 | +£0 | |
| Year 2 Profit | -£218.50 | +£0 | |
| Yr 2 Average monthly cash profit | -£22.54 | (-78.3%) | +£0.55 |
| Dividends | £1.15 | +£0 | |
| Profit from sales | -£241.35 | +£0 | |
| Average monthly cash profit | -£11.07 | (-38.4%) | +£0.12 |
| (Sold stocks profit + Dividends - Fees / Months) |
LION:Lionsgold sneaked up a tiny amount, so there was an £11 improvement in value. However, on Friday the shares were suspended as it appears the new emphasis of the company is too different from the listing paperwork. They have to be suspended pending a re-listing. This could take 3 or 4 months.
This account has been cursed from the word go! The only ray of sunshine in the whole debacle is that I don't need to report performance every week because nothing can happen. Vital man-minutes of my life won back!
This chart will still appear in the right panel of the page, but will flatline until the suspension is lifted.
Focus next week will be on the Vitafoods Europe event in Switzerland. OPTI:Optibiotix are exhibiting there with multiple partners, so there will be multiple opportunities to generate further contracts. There are also the NutraIngredients awards. Winning one of these would be huge. Slimbiome is a finalist for weight management ingredient of the year and LP-LDL is up for probiotic product of the year.
There's also the infamous press release that was published early and was meant to go out on 16th May announcing a deal with Seed Health even though a deal hadn't yet been made. We'll find out whether that cock-up by Business Insider US has delayed signing any contracts on 16th, when the article was meant to have been released.
Given the positive share price movement this week, and the high potential for positive news next week, then maybe it will be enough to take me back into profit. A 2p rise for OPTI:Optibiotix would be enough.
No comments:
Post a Comment